Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Clinical trial NCT07238569 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07238569
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Cancinoma (NPC)Nasopharangeal Cancer

Start date: 2025-12-01
Primary completion: 2029-12-01
Enrollment: 516

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.